"Studies evaluating the p21 biomarker will soon begin and the first data report is expected in mid-March."
Even so the statement notes about additional updates forthcoming the next true catalyst will the data points coming up in mid march. I would think that any positive news in that regards could be pushing the stock over three Dollars.
Actually wall street makes make money either way, usually the way down is faster than going up therefore smart money prefers a good short
I believe aapl needs to test 400. it is at support now and most likely will break through to test 400.
400 will hold. period. Its were support and downtrend meet and a great chance for the reversal,
If that break, 360, 320 250 and even 200 are in play!
On top of over-charging for their pricey products and ripping off dumb consumers who just need to have an apple product
If there would have been excellent earnings than the production cuts could have been justified, but this way it will be big trouble. Such a poor asset allocation management this company is demonstrating. Over 100 mill in the bank and they don't do anything with it. Very poor asset allocation management. Bad management. Bad,
You have to look hard to find a phone which is not better than the iphonne - that's an easy one
BBT played it save, what else is new
I do like the improvements on the return on assets to 1.2%, that was badly needed.
NIM at 3.84 % is good, above average.
Net charge-offs at 1.04% is good as well.
I like the report, particularly the much improved return on assets, but not sure if it's enough for wallstreet to propel it higher.
Still think a hike in dividends is due.